Engfeldt P, Arner P, Kimura H, Wahrenberg H, Ostman J
Scand J Clin Lab Invest. 1983 May;43(3):207-13. doi: 10.1080/00365518309168246.
Binding state for the selective alpha 2-adrenergic antagonist (3H)-yohimbine on isolated intact human subcutaneous abdominal fat cells is described in the present study. Specific binding was rapid, reversible, saturable and stereospecific. Adrenergic antagonists competed with (3H)-yohimbine binding in the order indicative of alpha-receptors. Competition studies with adrenergic antagonists revealed that (3H)-yohimbine binding sites displayed properties consistent with those of alpha 2-subtype. Saturation experiments demonstrated that (3H)-yohimbine specific binding was of high affinity with a dissociation constant (Kd) of 3.7 +/- 0.4 nmol/l and a maximum occupancy (BO) of 10.5 +/- 2.1 pmol/10(7) cells. The latter corresponded to approximately 600,000 alpha 2-receptors/fat cell. A significant (P less than 0.002) linear relationship was found between the fat cell volume and BO. A complete saturation experiment for the determination of Kd and BO could be performed using 0.5 g adipose tissue (0.5 ml isolated fat cells), which is 30 times less required when adipocyte membranes are used for these studies. It is concluded that the method can be used for the study of alpha 2-receptor properties and regulation in subcutaneous adipose tissue in a given individual.
本研究描述了选择性α2-肾上腺素能拮抗剂(3H)-育亨宾在分离的完整人皮下腹部脂肪细胞上的结合状态。特异性结合迅速、可逆、可饱和且具有立体特异性。肾上腺素能拮抗剂与(3H)-育亨宾结合的竞争顺序表明存在α-受体。与肾上腺素能拮抗剂的竞争研究显示,(3H)-育亨宾结合位点表现出与α2-亚型一致的特性。饱和实验表明,(3H)-育亨宾特异性结合具有高亲和力,解离常数(Kd)为3.7±0.4 nmol/l,最大占有率(BO)为10.5±2.1 pmol/10(7)个细胞。后者相当于每个脂肪细胞约600,000个α2-受体。发现脂肪细胞体积与BO之间存在显著(P<0.002)的线性关系。使用0.5 g脂肪组织(0.5 ml分离的脂肪细胞)即可进行测定Kd和BO的完全饱和实验,而使用脂肪细胞膜进行这些研究时所需的量是其30倍。结论是该方法可用于研究特定个体皮下脂肪组织中α2-受体的特性和调节。